Safety, Tolerability, and Efficacy of Selonsertib, Firsocostat, and Cilofexor in Adults With Nonalcoholic Steatohepatitis (NASH)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Gilead Sciences
Related studies linked through entity extraction aliases.
Sofosbuvir/Velpatasvir Fixed Dose Combination in Participants With Chronic Hepatitis C Virus Infection Who Have Received a Liver Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination (FDC) and Sofosbuvir/Velpatasvir FDC and Ribavirin in Participants With Chronic Genotype 3 HCV Infection and Cirrhosis
- Status
- COMPLETED
- Phase
- PHASE2
Effect of Andecaliximab on FEV1 in Adults With Cystic Fibrosis
- Status
- TERMINATED
- Phase
- PHASE2
Accelerated Pre-treatment Evaluation for HCV Infected Persons Who Inject Drugs
- Status
- COMPLETED
- Phase
- NA
Safety, Tolerability and Efficacy of Sofosbuvir, Velpatasvir, and Voxilaprevir in Subjects With Previous DAA Experience
- Status
- COMPLETED
- Phase
- PHASE2
Evaluation of HepCure Toolkit to Improve Harvoni Adherence
- Status
- COMPLETED
- Phase
- NA
Roll Over Study to Provide Idelalisib to Participants Previously Treated With the Investigational PI3Kδ Inhibitor, GS-9820
- Status
- TERMINATED
- Phase
- PHASE4
Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Participants With Chronic Genotype 2 HCV Infection
- Status
- COMPLETED
- Phase
- PHASE3
Uptake and Adherence to Daily Oral PrEP as a Primary Prevention Strategy for Young African Women: A Vanguard Study
- Status
- COMPLETED
- Phase
- PHASE4
Sofosbuvir/Velpatasvir Fixed-Dose Combination in HCV-Infected Adults Who Are Undergoing Liver Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination in Participants With Chronic Hepatitis C Virus Infection
- Status
- COMPLETED
- Phase
- PHASE3
Injectable Cabotegravir Compared to TDF/FTC For PrEP in HIV-Uninfected Men and Transgender Women Who Have Sex With Men
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
The Role of Endothelin-1 in Sickle Cell Disease
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy, Safety, and Tolerability of Ledipasvir/Sofosbuvir (LDV/SOF) Treatment for HIV/HCV Co-infected Participants Who Switch to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) or Emtricitabine/Rilpivirine/Tenofovir Alafenamide (F/R/TAF) Prior to LDV/SOF HCV Treatment
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Tolerability of Entospletinib in Combination With Systemic Corticosteroids as First-Line Therapy in Adults With Chronic Graft Versus Host Disease (cGVHD)
- Status
- TERMINATED
- Phase
- PHASE2
Study to Investigate the Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 and 4 HCV Infection With Autoimmune Disease
- Status
- UNKNOWN
- Phase
- PHASE4
Sequential Regimen of Bendamustin-Debulking Followed by Ofatumumab and Ibrutinib in CLL Patients (CLL2-BIO)
- Status
- COMPLETED
- Phase
- PHASE2
Chronic Hepatitis B and C Recall Northern Holland
- Status
- UNKNOWN
- Phase
- N/A
Study of Hepatitis C Treatment During Pregnancy
- Status
- COMPLETED
- Phase
- PHASE1